Nimish Shah's most recent trade in Apogee Therapeutics Inc. was a trade of 14,461 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Apogee Therapeutics Inc. | Nimish Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 14,461 | 14,461 | - | - | Stock Option (Right to Buy) | |
| Apogee Therapeutics Inc. | Nimish Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 10,370 | 10,370 | - | - | Stock Option (Right to Buy) | |
| Apogee Therapeutics Inc. | Nimish Shah | Director | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 13 Jul 2023 | 1,750,000 | 1,750,000 | - | 17 | 29,750,000 | Common Stock |
| Apogee Therapeutics Inc. | Nimish Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jul 2023 | 47,758 | 47,758 | - | - | Stock Option (Right to Buy) | |
| Instil Bio Inc | Nimish Shah | Director | 23 Mar 2021 | 5,100,866 | 5,100,866 | - | - | Common Stock | ||
| Instil Bio Inc | Nimish Shah | Director | 23 Mar 2021 | 4,250,722 | 0 | - | - | Series B Preferred Stock | ||
| Instil Bio Inc | Nimish Shah | Director | 23 Mar 2021 | 510,030 | 510,030 | - | - | Common Stock | ||
| Instil Bio Inc | Nimish Shah | Director | 23 Mar 2021 | 480,716 | 480,716 | - | - | Common Stock | ||
| Instil Bio Inc | Nimish Shah | Director | 23 Mar 2021 | 430,431 | 5,531,297 | - | - | Common Stock | ||
| Instil Bio Inc | Nimish Shah | Director | 23 Mar 2021 | 425,025 | 0 | - | - | Series B Preferred Stock | ||
| Instil Bio Inc | Nimish Shah | Director | 23 Mar 2021 | 400,597 | 0 | - | - | Series C Preferred Stock | ||
| Instil Bio Inc | Nimish Shah | Director | 23 Mar 2021 | 358,693 | 0 | - | - | Series C Preferred Stock | ||
| Instil Bio Inc | Nimish Shah | Director | Purchase of securities on an exchange or from another person at price $ 20.00 per share. | 23 Mar 2021 | 116,880 | 597,596 | - | 20 | 2,337,600 | Common Stock |
| Instil Bio Inc | Nimish Shah | Director | Purchase of securities on an exchange or from another person at price $ 20.00 per share. | 23 Mar 2021 | 104,640 | 5,635,937 | - | 20 | 2,092,800 | Common Stock |
| Instil Bio Inc | Nimish Shah | Director | Purchase of securities on an exchange or from another person at price $ 20.00 per share. | 23 Mar 2021 | 48,390 | 48,390 | - | 20 | 967,800 | Common Stock |
| Instil Bio Inc | Nimish Shah | Director | 23 Mar 2021 | 43,033 | 553,063 | - | - | Common Stock | ||
| Instil Bio Inc | Nimish Shah | Director | 23 Mar 2021 | 35,861 | 0 | - | - | Series C Preferred Stock | ||
| Instil Bio Inc | Nimish Shah | Director | Purchase of securities on an exchange or from another person at price $ 20.00 per share. | 23 Mar 2021 | 19,620 | 19,620 | - | 20 | 392,400 | Common Stock |
| Instil Bio Inc | Nimish Shah | Director | Purchase of securities on an exchange or from another person at price $ 20.00 per share. | 23 Mar 2021 | 10,470 | 563,533 | - | 20 | 209,400 | Common Stock |
| Instil Bio Inc | Nimish Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2021 | 52,000 | 52,000 | - | - | Stock Option (right to buy) |